China NMPA Product Recall - Disposable sterile injection needles

On February 18, 2019, BD Medical Devices (Shanghai) Co., Ltd. initiated a voluntary Class II recall for specific batches of its disposable sterile injection needles. This significant action was taken after the company identified an issue where a small quantity of blunt needles had inadvertently been included within the packaging of certain products. The affected medical devices are registered under CFDA (Imported) 2014 No. 3154621, with comprehensive details regarding the specific models, specifications, and batch numbers provided in an accompanying "Medical Device Recall Event Report Form." The recall was publicly announced by the National Medical Products Administration (NMPA) and reported through the Shanghai Food and Drug Administration (SFDA), demonstrating compliance with established regulatory protocols. A Class II recall classification signifies that the use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. BD Medical Devices (Shanghai) Co., Ltd. is undertaking this action to effectively remove the potentially compromised products from circulation, thereby mitigating any risk to patient safety. This incident underscores the critical importance of rigorous quality control processes within the medical device manufacturing sector and highlights the robust regulatory framework enforced by Chinese authorities to safeguard public health.